Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Down syndrome phenotypes: the consequences of chromosomal imbalance.Proc Natl Acad Sci U S A. 1994; 91: 4997-5001
- Mean age of mother, 1970–2000.Natl Vital Stat Rep. 2002; 51: 1-13
- Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997.Obstet Gynecol. 2000; 96: 979-985
- Births: final data for 2002.Natl Vital Stat Rep. 2003; 52: 1-113
- Centers for Disease Control and Prevention, Atlanta, GA.(Available at:) (Accessed May 30, 2010)
- A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.Obstet Gynecol. 2005; 106: 562-568
- Multi-marker maternal serum screening for chromosome abnormalities.in: Milunsky A. Milunsky J.A. Genetic disorders and the fetus. 6th edition. Wiley-Blackwell, Chichester2010: 771-818
- ACOG practice bulletin NO.77: screening for fetal chromosomal abnormalities.Obstet Gynecol. 2007; 109: 217-227
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.Lancet. 1998; 352: 343-346
- First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).Health Technol Assess. 2003; 7: 1-77
- First and Second Trimester Evaluation of Risk for Fetal Aneuploidy (FASTER): principal results of the NICHD multicenter Down syndrome screening study.N Engl J Med. 2005; 353: 2001-2011
- An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities.Am J Obstet Gynecol. 1984; 148: 886-894
- Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome.Lancet. 1984; 1: 926-929
- Maternal serum AFP secreening.N Engl J Med. 1978; 298: 738-739
- Risks associated with an elevated maternal serum alpha-fetoprotein level.Am J Obstet Gynecol. 1991; 165: 581-586
- Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities.Prenat Diagn. 1987; 7: 623-630
- Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.Am J Obstet Gynecol. 1990; 163: 1248-1253
- Second-trimester maternal serum markers in twin pregnancies with complete mole, report of 2 cases.Pediatr Dev Pathol. 2005; 8: 230-234
- Pseudo-partial moles, placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles.Histopathology. 2001; 39: 447-454
- Second trimester maternal serum analytes in triploid pregnancies, correlation with phenotype and sex chromosome complement.Prenat Diagn. 2001; 21: 680-686
- Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.Am J Obstet Gynecol. 1992; 167: 1021-1024
- Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.Prenat Diagn. 1998; 18: 1061-1067
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.Br J Obstet Gynaecol. 1988; 95: 330-333
- Low or absent unconjugated estriol in pregnancy, an indicator for steroid sulfatase deficiency detectable by fluorescence in situ hybridization and biochemical analysis.Prenat Diagn. 2002; 22: 1028-1032
- Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses.Am J Med Genet. 1999; 82: 355-358
- Major fetal abnormalities associated with positive screening test for Smith-Lemli-Opitz syndrome (SLOS).Prenat Diagn. 2007; 27: 409-414
- Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome.Prenat Diagn. 1992; 12: 801-806
- Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome.Prenat Diagn. 1995; 15: 359-362
- Ultrasound and biochemical assessment of first trimester pregnancy.in: Chapman M. Grudzinskas G. Chard T. The embryo: normal and abnormal development and growth. Springer-Verlag, New York1991: 181-194
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.Br Med J. 1992; 304: 867-869
- First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique.Ultrasound Obstet Gynecol. 2002; 19: 353-359
- Increased fetal nuchal translucency, possible involvement of early cardiac failure.Ultrasound Obstet Gynecol. 1997; 10: 265-268
- Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists.Am J Obstet Gynecol. 2009; 201 (e1–5): 97
- Second trimester prenatal ultrasound and screening for Down syndrome.Prenat Diagn. 2007; 27: 884
- Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters.N Engl J Med. 1999; 341: 461-467
- Second trimester serum markers.Semin Perinatol. 2005; 29: 203-208
- Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial.J Psychosom Obstet Gynaecol. 1993; 14: 185-196
- First-trimester screening for trisomies 21 and 18.N Engl J Med. 2003; 349: 1405-1413
- Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters.Semin Perinatol. 2005; 29: 252-257
- Sequential Down syndrome screening: the importance of first and second trimester test correlations when calculating risk.J Genet Couns. 2005; 14: 409-413
- Practical strategies in contingent sequential screening for Down syndrome.Prenat Diagn. 2005; 25: 645-652
- Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation.BMJ. 2009; 338: b138
- Role of second-trimester genetic sonography after Down syndrome screening.Obstet Gynecol. 2009; 114: 1189-1196
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
